Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Pregnancy Detection Kits
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Home Pregnancy Tests (HPT), one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$805.2 ... Read More
-
Prenatal Vitamin Supplements
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Gummy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$174.5 Million by the ... Read More
-
Airway Clearance Systems
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Positive Expiratory Pressure (PEP) System, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach ... Read More
-
Analytical Standards
... at a CAGR of 4.8% over the analysis period 2023-2030. Organic Analytical Standards, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.5 Billion by the end ... Read More
-
Anti-Inflammatory Therapeutics
... at a CAGR of 4.3% over the analysis period 2023-2030. Anti-Inflammatory Biologics, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$67.7 Billion by the end of ... Read More
-
Dengue Vaccine
... at a CAGR of 15.8% over the analysis period 2023-2030. Government Institutions End-Use, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$774.6 Million by the end ... Read More
-
Infectious Disease Diagnostics
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion ... Read More
-
Tobacco Alternative Gums
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. 2 mg Nicotine Content Gums, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More
-
Bone Grafts and Substitutes - Market Insights, Competitive Landscape and Market Forecast - 2030
... and Cell-Based Matrices], Xenografts, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spine, Others), End-User (Hospitals, Specialty Clinics, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a ... Read More
-
Herpes Zoster Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$134.0 Million by ... Read More
-
Global OC/LEP Market (2024 Edition): Analysis by Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... “Global OC/LEP Market (2024 Edition)” which provides a Combination Contraceptives Pills analysis of the Global OC/LEP industry in terms of market segmentation By Type (Combination Contraceptives Pills, Progestin-only Pills), By Distribution Channel (Hospital Pharmacies, Retail ... Read More
-
North America Women’s Health And Beauty Supplements Market Size, Share & Trends Analysis Report By Application (Women's Health, and Beauty), By Age Group, By Sales Channel, By Consumer Group, By Product, By Country and Growth Forecast, 2024 - 2031
... Forecast, 2024 - 2031 The North America Women’s Health And Beauty Supplements Market would witness market growth of 4.2% CAGR during the forecast period (2024-2031). The US market dominated the North America Others Market by ... Read More
-
Pharmaceutical Wholesalers (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Wholesalers (UK) report will tell you the companies that have ... Read More
-
Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, and Others (Diagnostic Services, etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) ... Read More
-
Respiratory Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of respiratory disorders and its risk factors, the rising geriatric ... Read More
-
Cranial Fixation and Stabilization Systems
... is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a ... Read More
-
Phytosterols
... of 7.7% over the analysis period 2023-2030. Beta-sitosterol, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth ... Read More
-
Italy In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) and Company Analysis, 2024-2032
... Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Complicated Urinary Tract Infections Market Insight, Epidemiology And Market Forecast - 2034
... uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis, and severe urosepsis. cUTI is a heterogeneous entity comprising multiple forms. The clinical presentation of symptomatic infection in patients with complicated urinary infection varies across a wide spectrum, ... Read More
-
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2034
... is further expected to increase by 2034. In the 7MM, JAKAFI/JAKAVI (ruxolitinib) accounted for the largest market size in 2023, with approximately USD 1,500 million. JAK inhibitors have emerged as the centerpiece of pharmacologic therapy ... Read More
-
Crowd Analytics
... at a CAGR of 20.6% over the analysis period 2023-2030. Crowd Analytics Solutions, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$3.2 Billion by the end ... Read More
-
Cushing`s Syndrome Diagnostics and Treatment
... is expected to reach US$819.7 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Cushing`s Syndrome Treatment, one of the segments analyzed in the report, is expected to record a ... Read More
-
Diabetic Food
... at a CAGR of 4.7% over the analysis period 2023-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$6.2 Billion by the end of ... Read More
-
Interventional Neurology Devices
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and ... Read More
-
Intraoral Scanners
... at a CAGR of 7.2% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$507.3 Million by the end of ... Read More